R

Rallybio Corp
D

RLYB

1.00000
USD
0.00
(0.00%)
Market Closed
Volume
2,273
EPS
0
Div Yield
0
P/E
-1
Market Cap
41,487,586
OverviewSignalsIdeasNews
Related Instruments
    H
    H
    -6.256
    (-4.25%)
    141.112 USD
    HLT
    -5.880
    (-2.74%)
    208.770 USD
    I
    IHG
    -4.500
    (-4.44%)
    96.880 USD
    MAR
    -8.740
    (-3.84%)
    218.790 USD
    W
    WH
    -0.800
    (-1.06%)
    74.920 USD
    More
News

Title: Rallybio Corp

Sector: Healthcare
Industry: Biotechnology
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.